-
-
Anti-ERBB2 / HER2 / CD340 Reference Antibody (gancotamab),, 50 микрограмм
-
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab),, 50 микрограмм
-
Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab),, 50 микрограмм
-
Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab),, 50 микрограмм
-
Anti-ERBB1 / EGFR / HER1 Reference Antibody (zalutumumab),, 50 микрограмм
-
Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2),, 50 микрограмм
-
Anti-ERBB1 / EGFR / HER1 Reference Antibody (tomuzotuximab),, 50 микрограмм
-
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Regeneron patent anti-EGFR),, 50 микрограмм
-
Anti-ERBB1 / EGFR / HER1 Reference Antibody (Shanghai Cancer Inst patent anti-EGFRvIII),, 50 микрограмм
-
Anti-ERBB1 / EGFR / HER1 Reference Antibody (pimurutamab),, 50 микрограмм
-
Anti-ERBB1 / EGFR / HER1 Reference Antibody (nimotuzumab),, 50 микрограмм
стр.: